Science Explorer Back to mapMap
Discussion
Researcher · Yokohama City University · Japan

Reo Tanoshima

Reo Tanoshima publishes mostly in Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, on topics such as Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation and Acute Myeloid Leukemia Research.

ORCID 0000-0003-4361-6967 OpenAlex
World rank
#3,947,324
of 7,710,434 ranked researchers
Rank in Japan
#104,587
of 383,136
Works
69
Citations
775
Citations per work
11.2
h-index
16
i10-index 21Top 34% in Hematology
Reo Tanoshima

What does Reo Tanoshima research?

Reo Tanoshima's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (5%).

Everything else: 33 works · 47.3% of their workHealth Sciences: 28 works · 41.2% of their workMedicine: 28 works · 41.2% of their workHematology: 10 works · 14.6% of their workPublic Health, Environmental and Occupational Health: 8 works · 11.1% of their workPediatrics, Perinatology and Child Health: 7 works · 9.5% of their workGenetics: 4 works · 6.0% of their workLife Sciences: 8 works · 11.5% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 6.5% of their workMolecular Biology: 4 works · 6.5% of their workImmunology and Microbiology: 3 works · 5.0% of their workImmunology: 3 works · 5.0% of their workTHEIR WORKReo Tanoshima69works
Life Sciences12%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3347.3%
    1. Medicine2841.2%
    1. Biochemistry, Genetics and Molecular Biology46.5%
    2. Immunology and Microbiology35.0%
  1. 1Hematology15% of their works
  2. 2Public Health, Environmental and Occupational Health11% of their works
  3. 3Pediatrics, Perinatology and Child Health10% of their works
  4. 4Molecular Biology6% of their works
  5. 5Genetics6% of their works
  6. 6Immunology5% of their works

Research topics

Which keywords describe Reo Tanoshima's research?

The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Lymphoblastic Leukemia, Childhood Cancer, Bone Marrow Niche, Graft-versus-Host Disease, Acute Myeloid Leukemia and AML.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Prognostic Factors273 topics
  2. Hematopoietic Stem Cells212 topics
  3. Acute Lymphoblastic Leukemia131 topic
  4. Childhood Cancer131 topic
  5. Bone Marrow Niche111 topic
  6. Graft-versus-Host Disease111 topic
  7. AML101 topic
  8. Acute Myeloid Leukemia101 topic
  9. Childhood Cancer Survivor Study91 topic
  10. Pediatric Quality of Life Inventory91 topic
  11. Cytochrome P45051 topic
  12. Pharmacogenetics51 topic
  13. Chronic Lymphocytic Leukemia41 topic
  14. Genetic Mutations41 topic
  15. Genomic Aberrations41 topic
  16. Glioblastoma41 topic
  17. Primary Immunodeficiency41 topic
  18. Temozolomide41 topic

Where does Reo Tanoshima work?

Reo Tanoshima's main affiliation in the publication record is Yokohama City University, Japan.

How many publications and citations does Reo Tanoshima have?

OpenAlex counts 69 works and 775 citations for Reo Tanoshima, an h-index of 16, ranking #3,947,324 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Reo Tanoshima. Posts are plain text and can be reported.